Category: Covid-19 Vaccine

Whooping cough, or pertussis, is cyclical with a rise in cases every three to five years.

A resurgence of whooping cough, or pertussis, is affecting several European countries.

The highly contagious respiratory infection, sometimes called the 100-day cough because the coughing associated with it can last weeks, is caused by a bacterium.

It is particularly dangerous for infants before vaccination. Heres what you need to know about it.

Increases in whooping cough have been reported since mid-2023 in Belgium, Croatia, Denmark, Spain, Sweden, and Norway, with particular increases this year in the Czech Republic and the Netherlands.

In the Czech Republic, pertussis cases are at the highest level reported since the 1960s, with more than 6,300 cases of the illness between January and the first week of April.

Spain had reported more than 8,200 cases by March, according to a report from health authorities, a large increase compared to the 1,200 cases reported in all of 2023.

The Netherlands reported more than 3,600 cases of whooping cough between January and March 2024, of which 228 were in infants.

Greek health authorities have also reported higher cases than the previous year, with 82 cases of whooping cough since the beginning of 2024. This is compared to just nine cases last year.

Typically, whooping cough cases will peak every three to five years.

The last peak in most European countries was either in 2012 or in 2018, and so it's quite logical to see now a resurgence of pertussis, Sylvain Brisse, Director of the Institut Pasteurs Biodiversity and Epidemiology of Bacterial Pathogens Unit, told Euronews Health.

The unusual thing is that due to the COVID pandemic and the infection control barriers [restrictions]... there was a delay in the resurgence, he added.

During the pandemic in 2020 and 2021, there were almost no cases of whooping cough, so both the pandemic delay and the pathogens cyclical nature could contribute to the latest resurgence, he added.

A spokesperson for the World Health Organization (WHO)s regional office in Europe specified that across the region, which encompasses Europe and parts of Central Asia, pertussis vaccination coverage has decreased since the pandemic.

Before 2019, almost 70 per cent of countries in the Region reported 90 per cent or higher coverage with a first booster dose of the vaccine. Coverage decreased during the pandemic and has not recovered since, now only about 50 per cent of countries have reported 90 per cent coverage, WHO Europe said.

They added, however, that increases can come from more reporting and awareness about the condition as well.

While symptoms start like a common cold, whooping cough can cause weeks of sudden, violent coughing fits. People can even vomit after the intense coughing fits.

Health authorities say that infants, babies, and young children may have pauses in breathing or turn blue.

The Netherlands public health institute said that more than half of babies with whooping cough are admitted to hospital and can occasionally die from pertussis.

People who are vaccinated, however, will generally have fewer symptoms and may not cough for as long.

Really the severe disease and the deaths are seen only in [newborns up to] six months more or less. They are very fragile, especially before three months when they have not been vaccinated yet or just after the first vaccination, said Brisse.

Unvaccinated adults, meanwhile, can cough for weeks, which is annoying. You don't sleep anymore. In many cases, you have a paroxysmal cough during the night. So that's that's a bit tiring and depressing, he said.

Pertussis is also highly contagious, with one person infecting on average 15 others.

Vaccines are available to prevent whooping cough, but according to Brisse, many countries only require them for children.

The vaccines protect well, but they protect for about 5 to 7 years, and then after that, people become susceptible again. That's why we would ideally need to re-vaccinate perhaps every ten years. But that's not the case, it's only for children in some countries, he said.

Vaccination is also recommended now in most European countries for pregnant women, which is an effective measure for protecting newborn babies from death.

In France, we [have] now recommend vaccination of pregnant womenbut the uptake of this measure is not very high, said Brisse.

In the UK, maternal vaccine uptake fell from nearly 75 per cent in December 2017 to 60 per cent in December 2023, health authorities said.

The Czech Republic imported110,000 vaccines from the UK, Canada, and France last week to vaccinate children and pregnant women as they respond to rising cases of whooping cough. Vaccines for adults will arrive this week, the health ministry said.

In addition to routine infant vaccination and vaccinating pregnant women in the second or third trimester, WHO Europe recommends that people who contract whooping cough are treated quickly with antibiotics and do not come into contact with infants, young children, or pregnant women.

When you are coughing from pertussis, it's recommended to not go to work, at least for two or three days when you take antibiotics and during the [whole] period of contagiousness, so three weeks, if you don't take antibiotics, said Brisse.

It's especially important to protect the young children or the neonates, so for example, if there was a birth and one of the parents coughs, you should avoid approaching the neonate, he added.

According to Public Health France, more than half of children infected with pertussis get it from one of their parents.

Go here to read the rest:

Why are whooping cough cases rising and what are the symptoms? - Euronews

Whooping cough is making a comeback in several parts of the world, with deaths reported in China, the Philippines, Czech Republic and the Netherlands, and outbreaks in countries including the US and UK.

The infection, whose scientific name is pertussis, is difficult to detect early and can be fatal, especially in children and babies. Thirteen deaths were reported in China in the first two months of 2024, with 32,380 cases reported more than 20 times higher than a year earlier, according to the National Disease Control and Prevention Administration. The Philippines this week said infection figures were 34 times higher than last year, with 54 deaths recorded in the first three months of 2024.

Read more from the original source:

All You Need to Know About Whooping Cough as Fatal Outbreaks Rise - Bloomberg

TRENTONAn investigation of Essex Countys $40 million COVID-19 vaccination program found widespread deficiencies, including lax oversight of spending and multiple violations of federal, state, and local procurement rules, the Office of the State Comptroller announced today.

OSCs COVID-19 Compliance and Oversight Project initiated the investigation after receiving an anonymous tip alleging fraud, waste, and abuse in the Essex County program. OSCs investigation found that the County improperly awarded millions of dollars as emergency contracts, bypassing the competitive bidding process, and while using emergency procurement methods, it failed to follow state and local requirements by not documenting the need for the emergency contract and not having the County Commissioners review and publicly approve each contract.

Additionally, the County spent $17 million on staffing costs but failed to implement an effective time-tracking system to verify that the workers were working the hours they logged. OSC found at least eight workers were also full-time employees of other government agencies. One worker was paid $130,000 over 11 months, yet the County didnt know who that person was or what the person did.

The governments obligation to protect taxpayer funds doesnt go away during an emergency, said Acting State Comptroller Kevin Walsh. As we found in Essex County, overusing emergency contracts and failing to monitor vendors and implement basic financial controls increases the likelihood of fraud, waste, and abuse risks that can and should be avoided.

Essex Countys COVID-19 vaccination program was launched in December 2020 and administered a total of 622,016 doses through August 2023. OSC reviewed nearly $10 million in payments made to 21 business vendors and about $4.6 million in payments made to 63 independent contractors and interviewed multiple county officials and staff. OSC found that even in 2022, the County continued to use emergency contracts without competitive, public bidding. Additionally, the County improperly used multi-year emergency contracts in several cases. Emergency procurement rules allow for a non-competitive bidding process when health and safety are at immediate risk but clearly prohibit multi-year contracts because of the lack of transparency and competition.

OSC also found that the County failed to enter into formal contracts with business vendors that laid out the terms required by the federal grants. This deficiency coupled with the failure to follow state and local emergency procurement rules potentially exposes these funds to recoupment by the federal government.

Essex County also failed to properly oversee its vendors. For instance, OSC found that 15 payments amounting to $871,211 were made to vendors without invoices, making it difficult to validate what goods or services were provided. From May 2020 through August 2021, the County also paid $1.29 million to the East Orange-based Dunton Consulting firm for robocall services. OSC found many of the firms invoices were riddled with errors and used a fee structure that varied wildly, without explanationall of the invoices were nonetheless paid.

When the County finally put the contract out for competitive, public bidding, the winning bidders fee structure was less than one cent per minute call. Duntons rate was four times as much. Based on Duntons last bill, the County could have saved $90,000 on that bill alone if it had contracted with the winning vendor one month earlier.

OSC discovered the County also paid Dunton twice for the same $110,514 in 2021. Instead of demanding immediate repayment of the federal funds, the County negotiated repayment with Dunton's accountant and entered into an agreement that amounts to a zero-interest loan. The generous terms of the agreement allow Dunton to repay less than the full amount of the improper payment over the next five years. The agreement was not signed by any County official, and its not clear how the County would monitor this long-term agreement.

The Countys oversight of more than 800 individuals working in the vaccination program also was deficient. Workers were able to log their hours remotely, from any device, and there was no enforcement of the sign-in sheets which could have provided a paper trail showing workers were on-site as required. Even after the County investigated and dismissed three workers who were found to be logging in hours when they were not at the vaccination sites, the County didnt change its timekeeping system to close this loophole, nor did it initiate a broader investigation at that time. OSC subsequently found numerous irregularities, such as individuals who held full-time jobs while working the same hours for the vaccination program.

The County also classified all of the workers as independent contractors, which meant that the County did not pay into unemployment funds or provide any benefits for those workers. OSC found that the County conducted an inadequate review to determine that all of the workers were contractors. OSC referred the matter to the NJ Department of Labor and Workforce Development.

OSC is also making referrals to appropriate agencies to address other findings from this report.

Read the full report.

Sign up now for OSC's newsletter.

To report government fraud, waste, mismanagement, or corruption, file a complaint with OSC or call 1-855-OSC-TIPS.

Continued here:

Investigation Uncovers Waste, Abuse in Essex County's $40 Million COVID-19 Vaccination Program - NJ.gov

This article has been reviewed according to ScienceX's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

trusted source

proofread

close

Every year in the U.S., human papillomavirus (HPV) causes about 37,000 new cases of cancer. These are cancers that could have been prevented with the HPV vaccine.

Unfortunately, only 38.6% of children ages 9 to 17 had received at least one dose of the HPV vaccine in 2022, according to a recent report by the Centers for Disease Control and Prevention.

UC Davis Health checked in with Dean Blumberg, chief of pediatric infectious diseases at UC Davis Children's Hospital, to learn more. He answers some frequently asked questions about HPV, the HPV vaccine and what families need to know to protect their children from HPV-associated cancers through adulthood.

HPV is the most common sexually transmitted disease in the U.S. It is spread through genital contact and can cause cancers.

People with HPV can be symptom-free, but they can still be infectious with no visible signs or symptoms. HPV causes a lot of different kinds of cancers in males and femalesincluding cervical cancers and other cancers. These include cancer of the vulva, vagina, penis or anus. HPV can also cause cancer in the throat, tongue and the tonsils.

Genital warts can also result from different types of HPV. Genital warts usually appear as a small bump or group of bumps in the genital area. They can be small or large, raised or flat, or shaped like a small cauliflower. A health care provider can usually diagnose warts by looking at the genital area.

Get vaccinated. The CDC recommends the HPV vaccination for all preteens (boys and girls) at age 11 or 12. Making sure preteens and teens receive their HPV vaccine now will protect them from these cancers when they are adults. It is a two-dose vaccine series for those ages 9-14. Older people can also get the vaccineup to age 45. For those who start the vaccine at age 15 to 45, or for immunocompromised people, it's a three-dose vaccine series.

To reduce the risk of HPV, those who are sexually active can also:

It's been found to have close to 100% efficacy, one month after a person completes the full vaccination series. It prevents future HPV infection and prevents the spread of HPV as well. I let patients know that this is a powerful cancer prevention tool.

The common side effects are pain, redness or swelling in the arm where the shot was given, fever, headache, muscle ache, nausea or dizziness. These side effects should improve within a day.

The vaccine provides a lifetime of protection. There is no need to get a booster for this.

But timing is important. The vaccine does not work to protect against HPV-associated cancers if someone already has HPV. It has to be administered before HPV exposure and infection. The vaccine is offered to preteens so the vaccine can provide that lasting protection into adulthood.

The rest is here:

Q&A: Does the HPV vaccine protect against cancers and genital warts? - Medical Xpress

Background to the scientific opinion

Outcomes

Implications

Different combinations of testing type, sample type, sample size, and sampling interval across different poultry species created a range of effective active surveillance options for the early detection of HPAI outbreaks during emergency vaccination as well as for demonstrating freedom from disease following preventive vaccination. The surveillance strategy should be selected according to the country's specific circumstances and resources.

In relation to active surveillance for the early detection of HPAI outbreaks in vaccinated farms during emergency vaccination:

For active surveillance to demonstrate freedom from disease in vaccinated areas following preventive vaccination:

Passive surveillance in unvaccinated farms in vaccinated areas is always recommended to enhance the overall sensitivity of the surveillance. During vaccination, passive surveillance is also applied to vaccinated flocks if, for example, an unusual increased mortality is observed between two consecutive sampling events.

Read the original post:

Vaccination of poultry against highly pathogenic avian influenza Part 2. Surveillance and mitigation measures - EFSA news

Measles outbreaks in the U.S. and abroad are raising health experts concern about the preventable, once-common childhood virus.

One of the worlds most contagious diseases, measles can lead to potentially serious complications. The best defense, according to experts? Get vaccinated.

Heres what to know about the year so far in measles.

Nationwide, measles cases already are nearly double the total for all of last year.

The U.S. Centers of Disease Control and Prevention documented 113 cases as of April 5. There have been seven outbreaks and most of U.S. cases 73% are linked to those flare-ups.

Still, the count is lower than some recent years: 2014 saw 667 cases and 2019 had 1,274.

The 2019 measles epidemic was the worst in almost three decades, and threatened the United States status as a country that has eliminated measles by stopping the continual spread of the measles virus.

The CDC on Thursday released a report on recent measles case trends, noting that cases in the first three months of this year were 17 times higher than the average number seen in the first three months of the previous three years.

While health officials seem to be doing a good job detecting and responding to outbreaks, the rapid increase in the number of reported measles cases during the first quarter of 2024 represents a renewed threat to elimination, the reports authors said.

The disease is still common in many parts of the world, and measles reaches the U.S. through unvaccinated travelers.

According to Thursdays report, most of the recent importations involved unvaccinated Americans who got infected in the Middle East and Africa and brought measles back to the U.S.

Health officials confirmed measles cases in 17 states so far this year, including cases in New York City, Philadelphia and Chicago.

More than half of this years cases come from the Chicago outbreak, where 61 people have contracted the virus as of Thursday, largely among people who lived in a migrant shelter.

The city health department said Thursday that cases are on the decline after health officials administered 14,000 vaccines in just over a month.

Measles is highly contagious. It spreads when people who have it breathe, cough or sneeze and through contaminated surfaces. It also can linger in the air for two hours.

Up to 9 out of 10 people who are susceptible will get the virus if exposed, according to the CDC.

Before a vaccine became available in 1963, there were some 3 million to 4 million cases per year, which meant nearly all American kids had it sometime during childhood, according to the CDC. Most recovered.

But measles can be much more than an uncomfortable rash, said Susan Hassig, an infectious disease researcher at Tulane University.

I think that people need to remember that this is a preventable disease, Hassig said. It is a potentially dangerous disease for their children.

In the decade before the vaccine was available, 48,000 people were hospitalized per year. About 1,000 people developed dangerous brain inflammation from measles each year, and 400 to 500 died, according to the CDC.

The measles, mumps and rubella (MMR) vaccine is safe and effective. It is a routine and recommended childhood vaccine that is split into two doses.

Research shows it takes a very high vaccination rate to prevent measles from spreading: 95% of the population should have immunity against the virus.

During the COVID-19 pandemic, national vaccination rates for kindergartners fell to 93% and remain there. Many pockets of the country have far lower rates than that. The drop is driven in part by record numbers of kids getting waivers.

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institutes Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

See the original post here:

US measles cases are up in 2024. What's driving the increase? - The Associated Press

The HPV vaccine prevents new infections of human papillomavirus (HPV), which is the most common cause of cervical cancer. Children can receive the vaccine before puberty, at 1112 years old.

The main mode of transmission for HPV is sexual activity. For this reason, it is important that people get the vaccine early, before there is any chance they will become sexually active.

This does not just apply to females 4 in 10 HPV-related cancer cases occur in males. In total, around 36,500 people in the United States receive an HPV-related cancer diagnosis every year.

So, should you get the HPV vaccine? For most young people, the answer is yes, with some exceptions. Read on to learn more.

The Centers for Disease Control and Prevention (CDC) recommends that all children receive an HPV vaccination around puberty. It is safe for children as young as 9 years old, but the typical age is 1112 years old.

If a person did not receive the vaccine at this age, they can still gain the maximum benefits if they are not yet sexually active.

The CDC recommends HPV vaccination to all people under 26 years old who have not received HPV vaccination before.

Most sexually active adults have exposure to HPV at some point. However, there are more than 100 types of HPV, and only some of them cause cancer. HPV can also cause genital warts.

Even if people are already sexually active, the vaccine may still prevent the most serious types of HPV. And if people have had HPV before, the vaccine may prevent them from contracting other strains.

Adults ages 2745 years should discuss the potential benefits of vaccination with a doctor. Vaccination after 45 years of age is not dangerous but may not offer significant benefit.

For most people, yes. Anyone can contract or transmit HPV, and anyone can develop HPV-related cancers. As a result, almost everyone can benefit from protection against this virus.

HPV vaccination prevents more than 90% of cancers that the virus can cause. In addition to cervical cancer, HPV can result in the following types of cancer:

While routine screening tests are available for cervical cancer, no such tests exist for these other forms of cancer. Doctors may not detect these cancers until they cause significant health problems.

Regular checkups are important to monitor for early signs of health conditions.

People should avoid the HPV vaccine for health reasons if:

People who have a moderate or severe temporary illness may want to delay vaccination until they are well.

For some other groups, HPV vaccines may be safe but may not be as effective as they could be. For example, the vaccine cannot treat an active HPV infection or prevent any harmful effects of that particular strain, but it could prevent someone from contracting additional types of HPV.

Yes, the HPV vaccine is safe for almost everyone. No serious negative effects have resulted from the vaccine, except for allergic reactions and fainting, which can happen after any vaccination.

Very rarely, people can have serious allergic reactions (anaphylaxis) in response to vaccines. For HPV vaccines, the rate of anaphylaxis is 3 cases per 1 million doses.

Otherwise, the side effects are mild and temporary. The most commonly reported effects are:

Each type of HPV vaccine that has been available in the United States has undergone strict safety testing before becoming publicly available. Scientists tested the vaccine Gardasil 9 in 15,000 people to determine its safety. There is no evidence that it causes any long-term harm.

In 2013, Japan temporarily suspended its HPV vaccination program in response to media reports of side effects. This led people to become scared of getting the vaccine. Some people also reinforced social stigma around getting the vaccine by alleging that only people who had many sexual partners needed to worry about getting HPV.

The fear and misinformation around HPV vaccines resulted in a dramatic decline in HPV vaccination coverage, from 70% to less than 1%, which lasted for 8 years.

While Japan reinstated the vaccination program in 2021, the uptake remains low. As a result, rates of cervical cancer have increased significantly.

There is no evidence that HPV vaccines cause serious side effects or that they encourage people to have many sexual partners.

The HPV vaccine works by stimulating the bodys natural immune response to HPV. It does this via virus-like particles (VLPs), which make the body think it has HPV when it does not.

VLPs consist of material from the surface of HPV, but they are not infectious and cannot replicate. Still, the immune system interprets their presence similarly to the presence of the real virus and begins to make antibodies.

If a person encounters HPV later on, their immune system will already be capable of fighting the virus, preventing infection.

All forms of the vaccine have a high efficacy of close to 100% at preventing strains of HPV that cause persistent infection.

In terms of health, the HPV shot has few downsides for most people. It offers safe and effective protection against viruses that can potentially cause cancer, and it usually has only minor side effects.

However, since the launch of HPV vaccination in the United States, distrust has grown, despite the consistent research showing its benefits. This may be due to inaccurate information that parents and caregivers are finding online.

Additionally, some people have concerns that HPV vaccination encourages potentially harmful sexual behavior. There is also no evidence to support this claim.

Most people, especially young people, should get the HPV vaccination. The benefits of the shot vastly outweigh the few risks. The HPV vaccine can prevent up to 90% of cervical cancers and may also prevent cancers of the mouth and throat, anus, vulva, and penis.

The side effects of the HPV vaccine are minor. The only known risk that can become serious is anaphylaxis, which is very rare.

A person who is considering the HPV vaccine for themselves or their child should discuss it with a trusted healthcare professional.

Read the original:

Should I get an HPV vaccine? Who it benefits and safety - Medical News Today

It's been more than four years since the first outbreak of COVID-19 hit the United States, but Sandra Fryhofer, MD, the AMAs liaison to the Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP), has a message she wants all physicians to share with their patients: COVID-19 still exists.

CDC surveys say less than 50% of people who get sick are testing themselves for COVID," said Dr. Fryhofer, who also is an internist and a member of ACIPs COVID-19 Vaccine Workgroup. We're all sick and tired of COVID, but the virus is still here. It's still circulating.

There are about 20,000 new hospital admissions and 2,000 deaths every week related to COVID-19, according to Dr. Fryhofer. That is why there are new recommendations for COVID-19 vaccines as well as isolation guidelines when sick.

Dr. Fryhofer discussed the key takeaways from those recommendations in a recent episode of AMA Update.

The updated COVID-19 vaccine became available in September 2023 and continues to be effective against JN. 1, the most dominant variant since January. Despite its effectiveness, more than half of people 65 or older have not received the updated COVID-19 vaccine.

This is alarming because most hospitalizations and deaths due to COVID-19 are in people who are 65 or older. Meanwhile, the highest COVID-19 mortality rates belong to people 75 or older.

Our immune systems don't work as well as we get older," Dr. Fryhofer said. "And immunity wanes more quickly in older age groups. This means more frequent vaccine doses are needed to maintain protection in this older population.

The new recommendations state that all adults 65 or older should get the added dose of the vaccine. But there is a required four-month interval between patients receiving the first dose of the vaccine and the updated vaccine.

Dr. Fryhofer explained that using the word "should" was debated, but ultimately it was chosen to stress the importance that this population stay current on vaccinations.

This stronger language is crystal clear and demonstrates ACIP's confidence in the importance of an additional dose of the vaccine in keeping our most vulnerable Americans protected, she said.

Get trusted insight from physicians on hot topics in todays health care headlinesdelivered to your inbox.

The hope, Dr. Fryhofer said, is that physicians can help all patientsparticularly the older populationunderstand the importance and effectiveness of the updated vaccine.

That's where physicians can really make a difference, she said. Adults who are vaccinatedor definitely plan to get vaccinatedwere more likely to report a health care provider recommended they get a COVID vaccine. This highlights the importance of physician recommendation."

Visit the AMA COVID-19 resource center for physicians for clinical information, guides and resources, and updates on advocacy and medical ethics.

Isolation guidelines have relaxed

The recommendation that received the most media attention is that individuals who test positive for COVID-19 no longer must isolate for five days.

With this new guidance, people who test positive for COVID-19 should stay home while sick, Dr. Fryhofer said. But you can return to work when you're feeling better and fever-free for 24 hours without taking fever-lowering medications.

She did recommend that if patients do test positive, they should wear a mask for the five days that follow and try to physically distance themselves from other people, particularly those who are considered high-risk individuals, such as people with weakened immune systems or adults 65 or older.

Dr. Fryhofer acknowledged people are tired of masks, testing and thinking about COVID-19. But vaccine fatigue, as she described it, is a concern physicians need to address. That starts by encouraging patients to get the updated vaccine, she said.

Our patients listen to usthey trust us, Dr. Fryhofer said. The new recommendations are meant to inform, not offend. COVID is here. It has not gone away. People are still being hospitalized. People are still dying from COVID.

AMA Update is your source for physician-focused news. Hear from physicians and other experts on trending public health concerns, practice issues and morebecause whos doing the talking matters. Catch every episode by subscribing to the AMAs YouTube channel or listen to all AMA podcasts at ama-assn.org/podcasts.

Follow this link:

Are you up to date on COVID-19 vaccine, isolation guidance? - American Medical Association

A Facebook post shared a photo of a New Jersey doctors office notice as evidence that COVID-19 vaccines are dangerous for student athletes.

TheApril 9 posthighlighted parts of the notice that said COVID-19 vaccinations affect your risk of sudden cardiac death on the playing field, and that the office may not be able to clear vaccinated athletes sports physicals without lab work and possibly an echocardiogram to rule out potential heart damage.

The post resonated with people who oppose COVID-19 vaccines. Amazing, even after they knew early on that the vaccine was affecting childrens hearts, they still kept pushing it for even younger kids, one commenter wrote. And they called us all names for 3 years, said another.

The post was flagged as part of Facebooks efforts to combat false news and misinformation on its News Feed. (Read more about ourpartnership with Facebook.)

The notice from the doctors office Morris Sussex Family Practice in Lake Hopatcong, New Jersey (now called Morris Sussex Direct Family Practice) is real. But one notice from a single doctors office does not equate to evidence that COVID-19 vaccines increase the risk of sudden cardiac arrests in young athletes.

(Screenshot/Facebook)

The notice was shared in a New Jersey schoolsFacebook groupin July 2022 and it has been on the practices website sinceat least March 2022, according to the Internet Archives Wayback Machine.

The notice was updatedin January 2023to say that having a COVID-19 infection also may lead the office to require additional tests for sports physicals. The noticenow says, COVID infection and COVID vaccinations affect your risk of sudden cardiac death.

But scientificstudieshave found no link between COVID-19 vaccinations and increased risk of cardiac arrest in young athletes. The narrative that the two are associated, widespread throughout the pandemic by groups opposed to COVID-19 vaccines, has been consistentlydebunkedbyjournalists, including PolitiFact.

Sports cardiology expertstold PolitiFactin January 2023 that they havent seen a sharp rise in athlete cardiac arrest episodes since the COVID-19 vaccines came out.

There is a rare, but increased risk of myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the lining outside the heart) mostlyin male teens and young adultswithin seven days of receiving a second dose of an mRNA COVID-19 vaccine, the Centers for Disease Control and Prevention has said.

A2022 studyin England showed the risk of myocarditis from COVID-19 infection is substantially higher than the risk of myocarditis after a vaccine.

Health experts say myocarditis usuallygoes away quicklybut severe cases can permanently damage the heart muscle andin some caseslead to sudden cardiac arrest.

But anApril CDC studythat focused on young people, although not specifically athletes, provides more evidence that theres no connection between the vaccines and sudden cardiac deaths.

Investigators examined Oregon death certificate data from June 2021 to December 2022 for 1,292 people ages 16 to 30. None of the death certificates listed vaccination as an immediate or contributing cause of death.

Of the total, 101 deaths could not exclude a cardiac cause. Vaccination records were available for 88 of those people, and 40 had received at least one dose of an mRNA COVID-19 vaccine. Of those 40, three died within 100 days of a vaccine dose.

Two of those people had underlying illnesses such as congestive heart failure and chronic respiratory failure, and the cause of death of the other was undermined natural cause. A follow-up with the medical examiner could neither confirm nor exclude a vaccine-associated adverse event as a cause of death for this decedent, the study said.

The data do not support an association of COVID-19 vaccination with sudden cardiac death among previously healthy young persons, the study concluded.

We rate the claim that a notice from a New Jersey doctors office proves that COVID-19 vaccines are dangerous for athletes False.

This fact check was originally published by PolitiFact, which is part of the Poynter Institute. See the sources for this fact check here.

Read the original:

A New Jersey doctors office notice not proof of COVID-19 vaccines danger to young athletes - Poynter

In a recent study published in the Morbidity and Mortality Weekly Report (MMWR), a group of researchers investigated the association between messenger Ribonucleic Acid (mRNA) coronavirus disease 2019 (COVID-19) vaccination and sudden cardiac death in Oregon residents aged 1630 years between June 2021 and December 2022.

Study: Assessment of Risk for Sudden Cardiac Death Among Adolescents and Young Adults After Receipt of COVID-19 Vaccine Oregon, June 2021December 2022. Image Credit:wacomka/ Shutterstock

In December 2020, the Food and Drug Administration (FDA) authorized two mRNA COVID-19 vaccines, initially allocated to healthcare workers and long-term care residents in the United States (U.S.) and later to older adults and those with high-risk conditions, before including healthy young individuals. By April 2021, all Oregonians aged 16 were eligible. Shortly afterward, reports emerged of myocarditis, especially in young males, with incidences estimated at 2.13 per 100,000, rising to 10.69 among young males in Israel. These cases were generally mild, with quick recoveries post-hospitalization. Despite no fatal myocarditis reports in Oregon to the Vaccine Adverse Event Reporting System (VAERS), sudden deaths among young athletes raised concerns, necessitating further research to clarify any vaccine linkage.

Under Oregon law, each death must have a completed death certificate maintained in a system that meets the data-quality standards set by the Centers for Disease Control and Prevention's (CDC) 's National Center for Health Statistics, including rigorous quality assurance reviews. Although there is no independent verification for the completeness of death certificate reporting, data on Oregon residents who die outside the state are also gathered through interstate agreements. Additionally, the ALERT Immunization Information System (IIS), which serves as Oregon's comprehensive immunization registry, required mandatory reporting of all COVID-19 vaccinations during the pandemic.

In an effort to examine the occurrence of sudden cardiac deaths possibly related to recent COVID-19 vaccination, researchers analyzed Oregon's death certificate database. They focused on identifying individuals aged 16-30 who died between June 1, 2021, and December 31, 2022, and whose cause of death included terms such as "sudden death," asystole," "cardiac arrest," "unknown," "undetermined," or "pending," "arrhythmia," and "myocarditis." For those cases where a cardiac cause was likely, the team cross-referenced with the ALERT IIS to check if the deceased had received an mRNA COVID-19 vaccine within 100 days before their death. The analysis also considered gender differences in the findings. This investigation was carried out by the Oregon Health Authority, which stated that the activity was not research but was conducted in accordance with federal law and state policy.

During the period from June 2021 to December 2022, in Oregon, a total of 1,292 deaths were recorded among individuals aged 16 to 30 years, with males comprising 72% (925) and females 28% (367) of the deceased.

For the male decedents, none of the death certificates identified vaccination as either an immediate or contributing cause of death. COVID-19 was mentioned as a cause in 17 (2%) of the male deaths. The majority of male deaths, 842 (91%), were attributed to noncardiac causes or other conditions. However, in 66 (7%) of the cases, excluding a cardiac cause was not possible based on the information on the death certificates. Within this subset, vaccination records were available for 58 (88%), with 24 (41%) having received at least one dose of an mRNA COVID-19 vaccine. Of these 24, two deaths occurred within 100 days post-vaccination. The first involved a male who died from congestive heart failure 21 days after vaccination, with contributing conditions including hypertension, obesity, diabetes, and sleep apnea. The second case, recorded 45 days post-vaccination, was labeled as an undetermined natural cause, with toxicology reports negative for common illegal substances but positive for prescribed medications. The medical examiner could not definitively link or rule out the vaccine as a contributing factor.

Among the female decedents, similarly, no death certificate cited vaccination as a cause. COVID-19 was noted in 13 (4%) cases. The majority, 319 (87%), had noncardiac reasons listed on their death certificates. For the remaining 35 (10%), where a cardiac cause could not be excluded, vaccination records were available for 30 (86%), and 16 (53%) had received at least one mRNA COVID-19 vaccine dose. Only one female, who died four days after receiving her vaccine dose, had her death recorded as natural, with the immediate cause being undetermined but related to chronic respiratory failure due to mitral stenosis.

To summarize, data from 40 U.S. healthcare systems from January 2021 to January 2022 showed that cardiac complications were significantly more common after COVID-19 infection than post-mRNA vaccination for those aged 5 years. In Oregon, from June 2021 to December 2022, of 1,292 deaths among residents aged 16-30, none were definitively linked to cardiac causes shortly after vaccination. During this period, 979,289 vaccine doses were administered to this group. Among 30 COVID-19-attributed deaths, only three had received the vaccine. Nationwide, vaccination is credited with preventing about 3.2 million deaths in its first two years.

Journal reference:

View post:

Oregon study finds no clear link between mRNA vaccines and sudden cardiac deaths in young people - News-Medical.Net